NUVB
Nuvation Bio Inc. Class A
$3.27
+$0.05(+1.55%)
41
Overall
--
Value
41
Tech
--
Quality
Market Cap
$1.10B
Volume
4.33M
52W Range
$1.54 - $4.09
Target Price
$7.50
Order:
Income Statement
| Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Total Revenue | -- | -- | -- | -- | $7.9M | ||
| Total Revenue | -- | -- | -- | -- | $7.9M | ||
| COST OF GOODS SOLD | |||||||
| Cost of Revenue | -- | -- | -- | -- | $7.1M | ||
| GROSS PROFIT | |||||||
| Gross Profit | -- | -- | -- | -- | $795.0K | ||
| OPERATING EXPENSES | |||||||
| Operating Expenses | $43.6M | $93.3M | $119.7M | $99.8M | $593.4M | ||
| Research & Development | $32.6M | $69.0M | $87.8M | $71.3M | $99.1M | ||
| Research Expense | $32.6M | $69.0M | $87.8M | $71.3M | $99.1M | ||
| Selling, General & Administrative | $11.2M | $24.9M | $32.8M | $29.5M | $70.2M | ||
| General & Administrative Expenses | $11.2M | $24.9M | $32.8M | $29.5M | $70.2M | ||
| Salaries & Wages | -- | -- | -- | $19.5M | $32.3M | ||
| Depreciation & Amortization | $100.0K | $200.0K | $200.0K | $200.0K | $-537.0K | ||
| Depreciation & Amortization | $100.0K | $200.0K | $200.0K | $200.0K | $-537.0K | ||
| Amortization | -- | -- | -- | -- | $-537.0K | ||
| Other Operating Expenses | -- | $-893.0K | $-2.5M | $-1.0M | $-1.8M | ||
| OPERATING INCOME | |||||||
| Operating income | $-43.6M | $-93.3M | $-119.7M | $-99.8M | $-592.6M | ||
| EBITDA | $-43.4M | $-93.1M | $-119.5M | $-75.6M | $-576.3M | ||
| NON-OPERATING ITEMS | |||||||
| Intinc | $1.9M | $3.0M | $7.4M | $24.6M | $27.1M | ||
| Net Non-Operating Interest Income/Expense | $1.9M | $3.0M | $7.4M | $24.6M | $27.1M | ||
| Gain on Sale of Securities | $218.0K | $-80.0K | $-1.2M | $-139.0K | $-12.0K | ||
| Other Income/Expense | $-218.0K | $-1.4M | $8.1M | $-6.1M | $1.2M | ||
| Other Special Charges | -- | $4.2M | $10.2M | $497.0K | $-1.0M | ||
| SPECIAL ITEMS | |||||||
| Restructring And Mn A Income | -- | -- | $7.4M | -- | -- | ||
| Special Income Charges | -- | -- | $-7.4M | -- | -- | ||
| PRE-TAX INCOME | |||||||
| EBIT | $-43.6M | $-93.3M | $-119.7M | $-75.8M | $-567.9M | ||
| Pre-Tax Income | $-41.7M | $-86.8M | $-104.2M | $-75.8M | $-567.9M | ||
| NET INCOME | |||||||
| Net Income | $-41.7M | $-86.8M | $-104.2M | $-75.8M | $-567.9M | ||
| Net Income (Continuing Operations) | $-41.7M | $-86.8M | $-104.2M | $-75.8M | $-567.9M | ||
| Net Income (Discontinued Operations) | $-41.7M | $-86.8M | $-104.2M | $-75.8M | $-567.9M | ||
| Net Income (Common Stockholders) | $-41.7M | $-86.8M | $-104.2M | $-75.8M | $-567.9M | ||
| Normalized Income | -- | -- | -- | -- | $-562.3M | ||
| TOTALS | |||||||
| Total Expenses | $43.6M | $93.3M | $119.7M | $99.8M | $600.5M | ||
| SHARE & EPS DATA | |||||||
| Average Shares Outstanding | $97.5M | $197.9M | $216.7K | $218.9K | $268.8K | ||
| Average Shares Outstanding (Diluted) | $97.5M | $197.9M | $216.7K | $218.9K | $268.8K | ||
| Shares Outstanding | $217.7M | $219.1M | $218.8M | $219.0M | $338.7M | ||
| Basic EPS | $-0.43 | $-0.44 | $-0.48 | $-0.35 | $-2.11 | ||
| Basic EPS (Continuing Operations) | $-0.43 | $-0.44 | $-0.48 | $-0.35 | $-2.11 | ||
| Diluted EPS | $-0.43 | $-0.44 | $-0.48 | $-0.35 | $-2.11 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $-0.48 | $-0.35 | $-2.11 | ||
| OTHER METRICS | |||||||
| Other Gand A | $11.2M | $24.9M | $32.8M | $29.5M | $70.2M | ||
| Restruct | -- | -- | $7.4M | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NUVB | $3.27 | +1.6% | 4.33M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Nuvation Bio Inc. Class A Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW